Clinical Trials Logo

Filter by:
  • Suspended  
  • « Prev · Page [2]
NCT ID: NCT00587457 Suspended - Leukemia, Lymphoma Clinical Trials

A Phase I,Multicenter, Dose Escalation Study of CAT-8015 in Patients With Chronic Leukemia

Start date: March 2007
Phase: Phase 1
Study type: Interventional

To demonstrate the safety of CAT-8015 at MTD dose.

NCT ID: NCT00382395 Suspended - Glaucoma Clinical Trials

SOLX Gold Shunt Versus Control Implant: Randomized Trial for Refractory Glaucoma

Start date: November 2005
Phase: Phase 3
Study type: Interventional

Study Objective: To establish the substantial equivalence of the SOLX Gold Shunt to commercially available aqueous shunts, specifically the Ahmed™ Glaucoma Valve Model FP7, in the ability to reduce intraocular pressure (IOP) associated with glaucoma in eyes where medical and conventional surgical treatments have failed.

NCT ID: NCT00211952 Suspended - Clinical trials for Non-Small Cell Lung Cancer

Adjuvant Celecoxib in Completely Resected pN1-2 NSCLC Patients

Start date: March 2004
Phase: Phase 3
Study type: Interventional

The aim of the study is to assess the influence of celecoxib on relapse-free survival in completely resected patients with poor prognosis indicated by metastatic involvement of intrapulmonary/hilar (pN1) or ipsilateral mediastinal (pN2) lymph nodes. Celecoxib, a selective oral COX-2 inhibitor, was found to exert significant anti-proliferative activity against a variety of tumor cell lines in vitro, including NSCLC. COX-2 is frequently up-regulated in NSCLC cell lines and archival tumor samples. Its high expression was also correlated with poor prognosis of the patients. A clinical trial addressing the role of celecoxib as adjuvant treatment in radically operated patients with high risk of relapse is warranted.